BWXT restarts TRISO fuel manufacturing
BWX Technologies Inc. announced on November 10 that its BWXT Nuclear Operations Group Inc. (BWXT NOG) subsidiary has completed its TRISO nuclear fuel line restart project and is actively producing fuel at its Lynchburg, Va., facility.
With the restart, BWXT now manufactures fuel across four commercial and government business lines, the company said. In addition to the TRISO line, BWXT operates fuel production lines at BWXT Nuclear Energy Canada, manufacturer of approximately half of the fuel powering the commercial reactor fleet in Ontario, Canada; BWXT subsidiary Nuclear Fuel Services, sole provider of nuclear fuel for the U.S. Navy; and BWXT’s Uranium Processing and Research Reactors operation, the only North American supplier of research reactor fuel elements for colleges, universities, and national laboratories.





Wisconsin-based SHINE Medical Technologies announced on November 4 that its Therapeutics division has made its first commercial sales of lutetium-177 to multiple customers. Lu-177 is a therapeutic isotope in demand by clinical trial sponsors because of its potential to treat a range of cancers.


The National Nuclear Security Administration has launched 


